Data Monitor

CLUSTER DATA

A large collection of Emerging Market Data – indicators and indices:

Click on a region, scroll down or  go2EMMA press

 

SECTOR DATA

A selection of return, risk, impact & fun ‘methodology’:

Click on a section, scroll down or return to Content

 

FRONTIERS TECH STORY

  • Suppression of the T-dependent antibody response following oral exposure to selected polycyclic aromatic compounds in B6C3F1/N mice

    IntroductionThe ability of polycyclic aromatic compounds (PACs), most notably benzo(a) pyrene [B(a)P], to suppress antibody responses in experimental animals is well documented. Very little information, however, is available on the immunotoxicity of related PACs despite their widespread presence in the environment. Additionally, there are several weaknesses in existing immunotoxicity databases for PACs in experimental animals, limiting their applicability in quantitative risk assessment. Careful characterization of strong positive and clear negative PACs is needed in order to lay the foundation for generating robust immunotoxicity data for structurally diverse PACs that have not yet been evaluated.MethodsIn the current study, adult B6C3F1/N female mice were treated daily for 28 consecutive days by oral administration of B(a)P to provide dose levels ranging between 2 and 150 mg/kg bodyweight/day. In addition, phenanthrene and pyrene, non-carcinogenic PACs, were tested at dose ranges between 12.5 and 800 mg/kg bodyweight/day and 3.1 and 200 mg/kg bodyweight/day, respectively. Immune assessments following PAC exposure included organ weights and immunopathology, hematology, quantification of immune cell types in the spleen, and T-dependent antibody response (TDAR) to sheep red blood cells (SRBC).ResultsBenzo(a)pyrene exposure resulted in significant decreases in lymphoid organ weights, immune cell populations in the spleen and TDAR. The most sensitive indicator for immunotoxicity from B(a)P treatment was suppression of antibody responses, where an ∼75% decrease occurred at a dose level of 9 mg/kg bodyweight/day and ∼32% decrease at the lowest tested dose of 2 mg/kg bodyweight/day. Antibody suppression was associated with significant immune cell loss in the spleen; however, it was clear that the suppression of the TDAR was more sensitive than cell loss indicating that cell function impairments were involved. Phenanthrene treatment also resulted in suppression of the antibody response but only at dose levels ≥50 mg/kg bodyweight/day without significant effects on other parameters, while pyrene showed no significant immune effects.ConclusionSuppression of the TDAR to SRBC immunization was the most sensitive immune endpoint being 33 times more sensitive than changes in liver weight, a commonly used outcome for risk assessment for PACs. Benzo(a)pyrene was the most potent PAC regarding suppression of humoral immunity whereas pyrene did not affect the immune responses tested. These studies lay the foundation for evaluating diverse PACs with a range of immunotoxicological potencies.

BELIEVE IT OR NOT

What’s wrong with this picture..?

Sep’2020

go2em

 

Jun’2020

go2em

 

Jan’21

go2em

Dec’2020

go2em

 

Nov’2020

go2em

 

Nov’2020

Georgia on my mind: What do Tbilisi and Atlanta have in common..? Well: Georgia!

go2em

 

Wanted

Send us a link to what you think Ripley would endorse 🙂 or comment one of the above

Write Us